Table 2.
Characteristics of COVID-19-positive participants by the immunization schedules.
| Total | Schedule 0–14 | Schedule 0–28 | |
|---|---|---|---|
| (n = 58) | (n = 34) | (n = 24) | |
| Age in years, n (%) | |||
| 18–59 | 48 (82.8) | 29 (85.3) | 19 (79.2) |
| 60–98 | 10 (17.2) | 5 (14.7) | 5 (20.8) |
| Sex, n (%) | |||
| Female | 31 (53.4) | 18 (52.9) | 13 (54.2) |
| Clinical score, n (%) | |||
| 2 (symptomatic, independent) | 55 (94.8) | 33 (97.1) | 22 (91.7) |
| 3 (symptomatic, assistance needed) | 1 (1.7) | 0 (0.0) | 1 (4.1) |
| 5 (hospitalized, oxygen by mask or nasal prongs) | 1 (1.7) | 1 (2.9) | 0 (0.0) |
| 7 (intubation and mechanical ventilation) | 1 (1.7) | 0 (0.0) | 1 (4.1) |
| Severity criteria, n (%) | |||
| Hospitalizations | 2 (3.4) | 1 (2.9) | 1 (4.1) |
| UCI admissions | 1 (1.7) | 0 (0.0) | 1 (4.1) |
| Deaths | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Health setting workers, n (%) | |||
| Yes | 28 (48.3) | 19 (55.9) | 9 (37.5) |
| Comorbidities, n (%) | |||
| ≥1 | 26 (44.8) | 14 (41.2) | 12 (50.0) |
| Comorbidities, n (%) | |||
| Cardiovascular disease | 4 (6.9) | 2 (5.9) | 2 (8.3) |
| Asthma and COPD * | 6 (10.3) | 3 (8.8) | 3 (12.5) |
| Diabetes | 3 (5.2) | 2 (5.9) | 1 (4.2) |
| Insulin resistance | 5 (8.6) | 1 (2.9) | 4 (16.7) |
| Arterial hypertension | 14 (24.1) | 9 (26.5) | 5 (20.8) |
| Allergic rhinitis | 7 (12.1) | 3 (8.8) | 4 (16.7) |
| Thyroid disease | 3 (5.2) | 3 (8.8) | 0 (0.0) |
| Obesity | 14 (24.1) | 5 (14.7) | 9 (37.5) |
| Dyslipidaemia | 0 (0.0) | 0 (0.0) | 0 (0.0) |
* COPD: chronic obstructive pulmonary disease. Data are presented as frequency and percentage of the total number of cases in each subgroup and were compared with chi-square test or Fisher exact test; all p values were higher than 0.05.